These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24167680)

  • 1. Patients' and clinicians' attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis.
    Kirschner M; Theodoridou A; Fusar-Poli P; Kaiser S; Jäger M
    Ther Adv Psychopharmacol; 2013 Apr; 3(2):89-99. PubMed ID: 24167680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.
    Jaeger M; Rossler W
    Psychiatry Res; 2010 Jan; 175(1-2):58-62. PubMed ID: 20004980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of patient and nurse attitudes to depot antipsychotic medication.
    Walburn J; Gray R; Gournay K; Quraishi S; David AS
    Br J Psychiatry; 2001 Oct; 179():300-7. PubMed ID: 11581109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study of the attitudes of patients in an early intervention service towards antipsychotic long-acting injections.
    Das AK; Malik A; Haddad PM
    Ther Adv Psychopharmacol; 2014 Oct; 4(5):179-85. PubMed ID: 25360242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatrists' opinion towards medication discontinuation in remitted first-episode psychosis: A multi-site study of the Asian Network for Early Psychosis.
    Hui CL; Wong AK; Leung WW; Lee EH; Chan SK; Chang WC; Chen EY; Chan TC; Swapna V; Tagata H; Tsujino N; Nemoto T; Mizuno M; Kang NI; Kim SW; Chung YC
    Early Interv Psychiatry; 2019 Dec; 13(6):1329-1337. PubMed ID: 30485671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists' Attitudes in Taiwan.
    Yen K; Liu CC; Lin YT; Chien YL; Hsieh MH; Liu CM; Hwang TJ; Liao WH; Hwu HG
    Neuropsychiatr Dis Treat; 2022; 18():465-475. PubMed ID: 35261544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia.
    Heres S; Reichhart T; Hamann J; Mendel R; Leucht S; Kissling W
    Eur Psychiatry; 2011; 26(5):297-301. PubMed ID: 20570493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychotics.
    Chue P; Emsley R
    CNS Drugs; 2007; 21(6):441-8. PubMed ID: 17521224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations.
    Achilla E; McCrone P
    Appl Health Econ Health Policy; 2013 Apr; 11(2):95-106. PubMed ID: 23494934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot perphenazine decanoate and enanthate for schizophrenia.
    David A; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD001717. PubMed ID: 16034865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing.
    Patel MX; De Zoysa N; Bernadt M; David A
    J Psychopharmacol; 2009 Sep; 23(7):789-96. PubMed ID: 18583438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicians' attitudes toward the use of long-acting injectable antipsychotics.
    Samalin L; Charpeaud T; Blanc O; Heres S; Llorca PM
    J Nerv Ment Dis; 2013 Jul; 201(7):553-9. PubMed ID: 23817151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot antipsychotics: Where do we stand?
    Khan AY; Salaria S; Ovais M; Ide GD
    Ann Clin Psychiatry; 2016 Nov; 28(4):289-298. PubMed ID: 27901520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review.
    Taylor M; Ng KY
    Aust N Z J Psychiatry; 2013 Jul; 47(7):624-30. PubMed ID: 23209308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes of psychiatrists toward antipsychotic depot medication.
    Heres S; Hamann J; Kissling W; Leucht S
    J Clin Psychiatry; 2006 Dec; 67(12):1948-53. PubMed ID: 17194274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Checking the plausibility of psychiatrists׳ arguments for not prescribing depot medication.
    Hamann J; Kissling W; Heres S
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1506-10. PubMed ID: 25037772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.